S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:VRTX

Vertex Pharmaceuticals News Headlines

$181.77
-0.13 (-0.07 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$181.00
$183.15
50-Day Range
$177.01
$201.33
52-Week Range
$176.36
$242.99
Volume1.41 million shs
Average Volume1.97 million shs
Market Capitalization$47.16 billion
P/E Ratio23.98
Dividend YieldN/A
Beta0.63

Media Mentions By Week

Vertex Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VRTX
News Sentiment

0.91

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VRTX Articles
This Week

12

6

VRTX Articles
Average Week

Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

Vertex Pharmaceuticals (NASDAQ VRTX) News Headlines Today

SourceHeadline
finance.yahoo.com logo3 No-Brainer Biotech Stocks to Buy Right Now
finance.yahoo.com - October 16 at 6:51 AM
fool.com logo2 Beaten-Down Growth Stocks to Buy Hand Over Fist
fool.com - October 9 at 10:29 AM
marketwatch.com logoVertex Pharmaceuticals Inc. stock falls Friday, underperforms market
marketwatch.com - October 8 at 10:26 PM
finance.yahoo.com logo3 Unstoppable Stocks to Buy in October
finance.yahoo.com - October 8 at 7:25 AM
nasdaq.com logoVRTX November 26th Options Begin Trading
nasdaq.com - October 7 at 3:42 PM
finance.yahoo.com logoBoston Biotech Star Vertex Struggles to Reprise Its One Big Hit
finance.yahoo.com - October 6 at 2:05 PM
nasdaq.com logoFirst Week of VRTX April 2022 Options Trading
nasdaq.com - October 4 at 12:42 PM
finance.yahoo.com logoAlcon's (ALC) Robust Product Line, Market Rebound Aid Growth
finance.yahoo.com - October 4 at 12:42 PM
forbes.com logoVertex Pharmaceuticals Stock Is Likely To Rebound From $180 Levels Currently
forbes.com - October 4 at 12:13 PM
MarketBeat logoVertex Pharmaceuticals (NASDAQ:VRTX) Sets New 12-Month Low at $179.35
americanbankingnews.com - October 1 at 12:24 PM
finance.yahoo.com logoVertex Pharmaceuticals (VRTX) Stock Moves -0.46%: What You Should Know
finance.yahoo.com - September 30 at 9:28 PM
nasdaq.com logoVRTX November 12th Options Begin Trading
nasdaq.com - September 30 at 4:27 PM
finance.yahoo.com logo4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years
finance.yahoo.com - September 30 at 6:05 AM
finance.yahoo.com logoSeagen (SGEN) Completes Enrollment in Colorectal Cancer Study
finance.yahoo.com - September 29 at 8:03 PM
finance.yahoo.com logoFDA Accepts Bristol Myers (BMY) sBLAs for Opdivo Combo for ESCC
finance.yahoo.com - September 28 at 11:17 PM
finance.yahoo.com logoGot $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter
finance.yahoo.com - September 28 at 8:01 AM
finance.yahoo.com logo3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
finance.yahoo.com - September 28 at 8:01 AM
finance.yahoo.com logoShould You Now Consider Selling Your Vertex Pharmaceuticals (VRTX) Stake?
finance.yahoo.com - September 27 at 3:27 PM
finance.yahoo.com logoSeptember Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
finance.yahoo.com - September 25 at 9:46 AM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Disney, Adobe, Wells Fargo, IHS Markit and Vertex Pharma
finance.yahoo.com - September 24 at 12:36 PM
MarketBeat logoVertex Pharmaceuticals (NASDAQ:VRTX) Hits New 12-Month Low at $182.20
americanbankingnews.com - September 24 at 12:18 PM
finance.yahoo.com logoVertex's Supplement to a New Drug Submission for KALYDECO® (ivacaftor) for Patients with Cystic Fibrosis Between the Ages of 4 Months and 18 Years with the R117H Mutation in the CFTR Gene Accepted for Priority Review by Health Canada
finance.yahoo.com - September 22 at 12:46 PM
finance.yahoo.com logoIs Now the Time to Ditch Pharma Stocks?
finance.yahoo.com - September 21 at 10:40 AM
finance.yahoo.com logoLoomis Sayles Growth Portfolio Buys Vertex Pharmaceuticals Inc
finance.yahoo.com - September 17 at 7:45 PM
finance.yahoo.com logoHere's Why You Should Retain QIAGEN (QGEN) Stock For Now
finance.yahoo.com - September 16 at 12:34 PM
nasdaq.com logoInteresting VRTX Put And Call Options For January 2024
nasdaq.com - September 14 at 6:50 PM
finance.yahoo.com logoVertex to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 15th
finance.yahoo.com - September 13 at 9:36 AM
nasdaq.com logoNoteworthy Friday Option Activity: AMAT, URI, VRTX
nasdaq.com - September 10 at 3:09 PM
finance.yahoo.com logoVertex Pharmaceuticals Is in a Long-Term Decline
finance.yahoo.com - September 10 at 3:09 PM
finance.yahoo.com logo3 Top Healthcare Stocks to Buy for September
finance.yahoo.com - September 10 at 6:58 AM
finance.yahoo.com logoPerrigo (PRGO) to Acquire Another Self-Care Company HRA Pharma
finance.yahoo.com - September 9 at 3:43 PM
finance.yahoo.com logoWhat Makes Vertex (VRTX) a New Strong Buy Stock
finance.yahoo.com - September 9 at 3:43 PM
bizjournals.com logoObsidian Therapeutics eyes IPO after $115M fundraise
bizjournals.com - September 9 at 10:42 AM
nasdaq.com logoCentene, ACADIA: Why These Out Of Favor Health Care Stocks Are Worth A Look
nasdaq.com - September 6 at 2:46 AM
finance.yahoo.com logoPfizer (PFE) Begins Study on RSV Vaccine in Older Adults
finance.yahoo.com - September 3 at 3:59 PM
nasdaq.com logoOctober 22nd Options Now Available For Vertex Pharmaceuticals (VRTX)
nasdaq.com - September 2 at 4:04 PM
finance.yahoo.com logo3 Large Biotech Stocks Worth Adding to Your Portfolio
finance.yahoo.com - September 2 at 4:04 PM
finance.yahoo.com logoDespite Recent Underperformance, Institutions are Liking Vertex Pharmaceuticals (NASDAQ:VRTX)
finance.yahoo.com - August 27 at 2:50 PM
bizjournals.com logoThe Petri Dish: MIT's Sabatini ousted, Vertex inks another CRISPR deal
bizjournals.com - August 26 at 8:52 PM
nasdaq.com logoOctober 8th Options Now Available For Vertex Pharmaceuticals (VRTX)
nasdaq.com - August 26 at 8:52 PM
finance.yahoo.com logoVertex Announces Publication in The New England Journal of Medicine of Phase 3 Results for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People With Cystic Fibrosis
finance.yahoo.com - August 26 at 3:46 PM
nasdaq.com logoBullish insiders bet US$8.2m on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
nasdaq.com - August 25 at 3:56 PM
finance.yahoo.com logoWill Weakness in Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Prove Temporary Given Strong Fundamentals?
finance.yahoo.com - August 25 at 3:56 PM
finance.yahoo.com logoHealth Canada Grants Marketing Authorization for KALYDECO® (ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants With CF as Early as Four Months of Age
finance.yahoo.com - August 25 at 3:56 PM
sg.finance.yahoo.com logoVertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies
sg.finance.yahoo.com - August 24 at 7:35 AM
finance.yahoo.com logoVertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies
finance.yahoo.com - August 24 at 7:35 AM
finance.yahoo.com logo2 Biopharma Growth Stocks to Buy and Hold for Years
finance.yahoo.com - August 21 at 7:25 AM
finance.yahoo.com logo4 Healthcare Stocks That Analysts Love
finance.yahoo.com - August 19 at 2:59 PM
finance.yahoo.com logo3 Beaten-Down Biotech Stocks to Buy Right Now
finance.yahoo.com - August 18 at 6:53 AM
finance.yahoo.com logo3 Smartest Healthcare Stocks to Buy With $1,000 Right Now
finance.yahoo.com - August 18 at 6:53 AM
Get Vertex Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.